Zobrazeno 1 - 10
of 28
pro vyhledávání: '"S. A. Edelman"'
Autor:
William H. Polonsky, Ruo-Ding Tan, J. Y. Zhu, Ginger S. Carls, S. V. Edelman, Edward Tuttle, J. Yee
Publikováno v:
Obesity Science & Practice. 3:342-351
SummaryAims The study aims to examine real-world weight change and the role of medication adherence among patients with type 2 diabetes who initiated one of three drug classes: glucagon-like peptide-1 receptor agonist (GLP-1RA), dipeptidyl peptidase-
Publikováno v:
Diabetes. 41:1076-1083
Publikováno v:
Diabetes. 39:955-964
Publikováno v:
Diabetes. 39:965-974
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 258:E16-E23
The single-compartment pool fraction model, when used with the hyperinsulinemic glucose clamp technique to measure rates of glucose turnover, sometimes underestimates true rates of glucose appearance (Ra) resulting in negative values for hepatic gluc
Publikováno v:
International journal of clinical practice. 60(12)
Diabetes treatment has traditionally focused on correcting insulin deficiency with exogenous insulin and oral agents designed to enhance insulin secretion or insulin sensitivity in peripheral tissues. The more recent view of diabetes as a disease tha
Autor:
S V, Edelman
Publikováno v:
Effective clinical practice : ECP. 4(4)
Publikováno v:
The New York state dental journal. 67(5)
The dentist can maximize the oral rehabilitation of the stroke patient's weak or paralyzed oral musculature, resulting in dysfunctional speech, swallowing and deglutition, with the use of palatal lift and palatal augmentation prostheses. The study de
Autor:
B A, Ramlo-Halsted, S V, Edelman
Publikováno v:
Primary care. 26(4)
This article reviews the natural history of type 2 diabetes and emphasizes that the disease is a continuum from impaired glucose tolerance and impaired fasting glucose to frank diabetes. Understanding this natural history aids the clinician in identi
Autor:
S V, Edelman
Publikováno v:
Advances in internal medicine. 43
Type II diabetes is a common disorder whose prevalence is increasing in the United States and throughout the world. Type II diabetes is also associated with several other metabolic abnormalities such as central obesity, hypertension, and dyslipidemia